Annual summary of publications
Publications (original articles or review articles) published in 2014 from OUS - Section of Preventive Medicine
46 publications found
Physical activity and the risk of preeclampsia: a systematic review and meta-analysis
Epidemiology, 25 (3), 331-43
DOI 10.1097/EDE.0000000000000036, PubMed 24713878
Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis
JAMA, 311 (15), 1536-46
DOI 10.1001/jama.2014.2269, PubMed 24737366
Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene
Atherosclerosis, 234 (1), 30-3
DOI 10.1016/j.atherosclerosis.2014.02.005, PubMed 24589565
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials
J Am Coll Cardiol, 64 (5), 485-94
DOI 10.1016/j.jacc.2014.02.615, PubMed 25082583
Occupational hazard exposure and general health profile of welders in rural Delhi
Indian J Occup Environ Med, 18 (1), 21-6
DOI 10.4103/0019-5278.134953, PubMed 25006312
Sex differences in cardiovascular outcome during progression of aortic valve stenosis
Heart, 101 (3), 209-14
DOI 10.1136/heartjnl-2014-306078, PubMed 25301859
Uric acid and clinical correlates of endothelial function in kidney transplant recipients
Clin Transplant, 28 (10), 1167-76
DOI 10.1111/ctr.12435, PubMed 25124959
Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension
Hypertension, 63 (5), 991-9
DOI 10.1161/HYPERTENSIONAHA.114.03246, PubMed 24591332
Hypersensitivity pneumonitis in a cluster of sawmill workers: a 10-year follow-up of exposure, symptoms, and lung function
Int J Occup Environ Health, 20 (2), 167-73
DOI 10.1179/2049396714Y.0000000063, PubMed 24999852
Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial
Am J Cardiol, 114 (10), 1518-22
DOI 10.1016/j.amjcard.2014.08.016, PubMed 25267716
[Physical activity, smoking and mortality among men who participated in the Oslo studies of 1972 and 2000]
Tidsskr Nor Laegeforen, 134 (18), 1743-8
DOI 10.4045/tidsskr.14.0073, PubMed 25273247
Increased predictive ability of BMI but not other risk factors with time in men: 39-year follow-up of total mortality in the Oslo Study
Obes Facts, 7 (5), 311-21
DOI 10.1159/000368567, PubMed 25300406
Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment
Atherosclerosis, 233 (2), 561-567
DOI 10.1016/j.atherosclerosis.2014.01.022, PubMed 24530965
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF
Heart, 100 (24), 1946-53
DOI 10.1136/heartjnl-2014-305763, PubMed 25217488
Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial
Eur Heart J, 35 (21), 1411-20
DOI 10.1093/eurheartj/ehu051, PubMed 24616337
Efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia not adequately controlled with current lipid-lowering therapy: design and rationale of the ODYSSEY FH studies
Cardiovasc Drugs Ther, 28 (3), 281-9
DOI 10.1007/s10557-014-6523-z, PubMed 24842558
Physician (investigator) inertia in apparent treatment-resistant hypertension - insights from large randomized clinical trials. Lennart Hansson Memorial Lecture
Blood Press, 24 (1), 1-6
DOI 10.3109/08037051.2014.946787, PubMed 25162203
Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results
J Hypertens, 32 (12), 2488-98; discussion 2498
DOI 10.1097/HJH.0000000000000331, PubMed 25144296
Gregorius Agricola memorial lecture: Lung cancer-A work-related disease for 500 years, as predicted by Agricola
J Trace Elem Med Biol, 31, 214-8
DOI 10.1016/j.jtemb.2014.05.010, PubMed 25022333
Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study
Diabetes Care, 38 (3), 355-64
DOI 10.2337/dc13-2762, PubMed 25205142
Adjusting parameters of aortic valve stenosis severity by body size
Heart, 100 (13), 1024-30
DOI 10.1136/heartjnl-2013-305225, PubMed 24780909
Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010
J Am Heart Assoc, 3 (6), e001236
DOI 10.1161/JAHA.114.001236, PubMed 25468658
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review
Atherosclerosis, 235 (2), 299-309
DOI 10.1016/j.atherosclerosis.2014.05.917, PubMed 24908240
Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension
Curr Med Res Opin, 30 (9), 1715-24
DOI 10.1185/03007995.2014.924912, PubMed 24834808
Hyperresponders vs. nonresponder patients after renal denervation: do they differ?
J Hypertens, 32 (12), 2422-7; discussion 2427
DOI 10.1097/HJH.0000000000000347, PubMed 25375391
Eligibility for renal denervation: experience at 11 European expert centers
Hypertension, 63 (6), 1319-25
DOI 10.1161/HYPERTENSIONAHA.114.03194, PubMed 24664290
Renal denervation after Symplicity HTN-3: an update
Curr Hypertens Rep, 16 (8), 460
DOI 10.1007/s11906-014-0460-x, PubMed 24913923
Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients
Transplantation, 98 (11), 1219-25
DOI 10.1097/TP.0000000000000205, PubMed 24999963
Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials
J Am Coll Cardiol, 63 (13), 1278-1288
DOI 10.1016/j.jacc.2014.01.006, PubMed 24509273
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Lancet, 385 (9965), 331-40
DOI 10.1016/S0140-6736(14)61399-4, PubMed 25282519
Impact of obesity and nonobesity on grading the severity of aortic valve stenosis
Am J Cardiol, 113 (9), 1532-5
DOI 10.1016/j.amjcard.2014.01.429, PubMed 24630788
Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention
Ann Rheum Dis, 74 (8), 1544-50
DOI 10.1136/annrheumdis-2013-204636, PubMed 24699940
Heart rate as a predictor of stroke in high-risk, hypertensive patients with previous stroke or transient ischemic attack
J Stroke Cerebrovasc Dis, 23 (10), 2814-2818
DOI 10.1016/j.jstrokecerebrovasdis.2014.07.009, PubMed 25304725
Sinonasal adenoid cystic carcinoma following formaldehyde exposure in the operating theatre
J Occup Med Toxicol, 9 (1), 43
DOI 10.1186/s12995-014-0043-4, PubMed 25550707
The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice
Atheroscler Suppl, 15 (1), 1-15
DOI 10.1016/j.atherosclerosissup.2014.04.001, PubMed 24840509
Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study
Lancet Diabetes Endocrinol, 2 (6), 455-63
DOI 10.1016/S2213-8587(14)70006-3, PubMed 24731671
Maternal life course socio-economic position and offspring body composition at birth in a multi-ethnic population
Paediatr Perinat Epidemiol, 28 (5), 445-54
DOI 10.1111/ppe.12137, PubMed 25060595
[Renal sympathetic denervation in treatment-resistant hypertension]
Tidsskr Nor Laegeforen, 134 (1), 32-6
DOI 10.4045/tidsskr.13.0276, PubMed 24429753
Darapladib for preventing ischemic events in stable coronary heart disease
N Engl J Med, 370 (18), 1702-11
DOI 10.1056/NEJMoa1315878, PubMed 24678955
The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: a randomized, controlled study
Blood Press, 24 (1), 48-54
DOI 10.3109/08037051.2014.976979, PubMed 25483553
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Lancet, 385 (9965), 351-61
DOI 10.1016/S0140-6736(14)61183-1, PubMed 25262344
Symptoms of nicotine toxicity in subjects achieving high cotinine levels during nicotine replacement therapy
Nicotine Tob Res, 16 (9), 1266-71
DOI 10.1093/ntr/ntu076, PubMed 24852574
Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach
Eur J Hum Genet, 23 (3), 381-7
DOI 10.1038/ejhg.2014.101, PubMed 24916650
Health effects after firing small arms comparing leaded and unleaded ammunition
Inhal Toxicol, 26 (14), 873-9
DOI 10.3109/08958378.2014.970783, PubMed 25373830
Statins for children with familial hypercholesterolemia
Cochrane Database Syst Rev (7), CD006401
DOI 10.1002/14651858.CD006401.pub3, PubMed 25054950
Design considerations for clinical trials of autonomic modulation therapies targeting hypertension and heart failure
Hypertension, 65 (1), 5-15
DOI 10.1161/HYPERTENSIONAHA.114.04057, PubMed 25350982